KANEBAKO Makoto | Fuji Research Laboratories, Pharmaceutical Division, Kowa Company, LTD.
スポンサーリンク
概要
- Kanebako Makotoの詳細を見る
- 同名の論文著者
- Fuji Research Laboratories, Pharmaceutical Division, Kowa Company, LTD.の論文著者
関連著者
-
KANEBAKO Makoto
Fuji Research Laboratories, Pharmaceutical Division, Kowa Company, LTD.
-
Kanebako Makoto
Fuji Research Laboratories, Pharmaceutical Division, Kowa Co., Ltd.
-
Takayama Kozo
Department of Pharmaceutics, Hoshi University
-
Takayama Kozo
Department Of Pharmaceutics Faculty Of Pharmaceutical Sciences Hoshi University
-
INAGI Toshio
Fuji Research Laboratories, Pharmaceutical Division, Kowa Company, LTD.
-
Takayama Kozo
Department of Drug Delivery Research, Hoshi University
-
Inagi Toshio
Fuji Research Laboratories, Pharmaceutical Division, Kowa Co., Ltd.
-
Takayama K
Hoshi Univ. Tokyo Jpn
-
Takayama Kozo
Dep. Of Pharmaceutics Hoshi Univ.
-
Inagi T
Kowa Co. Ltd. Shizuoka Jpn
-
Kanebako M
Kowa Co. Ltd. Shizuoka Jpn
-
TERADA Katsuhide
Faculty of Pharmaceutical Sciences, Toho University
-
Terada Katsuhide
Faculty Of Pharmaceutical Sciences Chiba University
-
INAGI Toshio
Department of Pharmaceutics, Hoshi University
-
INAGAKI Toshio
Fuji Research Laboratories. Pharmaceutical Division
-
Kanebako Makoto
Fuji Research Laboratories. Pharmaceutical Division
-
Miura Hiroshi
Fuji Research Laboratories, Pharmaceutical Division, Kowa Co., Ltd.
-
Shirai Hiroyuki
Fuji Research Laboratories, Pharmaceutical Division, Kowa Co., Ltd.
-
Nakao Hiroshi
Fuji Research Laboratories, Pharmaceutical Division, Kowa Co., Ltd.
著作論文
- Evaluation of Skin Barrier Function Using Direct Current II : Effects of Duty Cycle, Waveform, Frequency and Mode
- Evaluation of Skin Barrier Function Using Direct Current I : Effects of Conductivity, Voltage, Distance between Electrodes and Electrode Area
- Transdermal Delivery of Indomethacin by lontophoresis
- Evaluation of Skin Barrier Function Using Direct Current III: Effects of Electrode Distance, Boundary Length and Shape
- Influence of Particle Design on Oral Absorption of Poorly Water-Soluble Drug in a Silica Particle–Supercritical Fluid System